Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm.

about

Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm.

Item

http://www.wikidata.org/entity/Q47157031

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@en

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@nl

type

Item

label

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@en

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@nl

prefLabel

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@en

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@nl

P1476

Intensity-modulated fractionat ...... sparing optic nerve & chiasm.

@en

P2093

Chae-Yong Kim

http://www.w3.org/2001/XMLSchema#string

Hak Jae Kim

http://www.w3.org/2001/XMLSchema#string

Hyeon Kang Koh

http://www.w3.org/2001/XMLSchema#string

In Ah Kim

http://www.w3.org/2001/XMLSchema#string

Jae Sung Kim

http://www.w3.org/2001/XMLSchema#string

Jung Ho Han

http://www.w3.org/2001/XMLSchema#string

Yu Jung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Radiotherapy and radiosurgery for benign skull base meningiomas.

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.

Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes

Quality assurance in fractionated stereotactic radiotherapy.

P304

307-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296373

http://www.w3.org/2001/XMLSchema#string

P932

5658840

http://www.w3.org/2001/XMLSchema#string